The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm

Behavioural Brain Research

Volumn 270, Issue , 2014, Pages 206-212

  Rygula, Rafal ^a   Szczech, Ewa ^a   Papciak, Justyna ^a   Nikiforuk, Agnieszka ^a   Popik, Piotr ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Ambiguous cue; Cocaine; Cognitive bias; Mazindol; Rat

Indexed keywords

COCAINE; MAZINDOL; DOPAMINE UPTAKE INHIBITOR;

AMBIGUITY; AMBIGUOUS CUE INTERPRETATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; COGNITIVE BIAS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; MALE; MENTAL TASK; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OPTIMISM; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; ANIMAL; COGNITION; DECISION MAKING; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECTS; SPRAGUE DAWLEY RAT;

ANIMALS; COCAINE; COGNITION; CUES; DISCRIMINATION LEARNING; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; JUDGMENT; MALE; MAZINDOL; NEUROPSYCHOLOGICAL TESTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84901496344     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.026     Document Type: Article

References (47)

1. Brittlebank A.D., Scott J., Williams J.M., Ferrier I.N. Autobiographical memory in depression: state or trait marker?. Br J Psychiatry 1993, 162:118-121.
2. Murphy F.C., Sahakian B.J., Rubinsztein J.S., Michael A., Rogers R.D., Robbins T.W., et al. Emotional bias and inhibitory control processes in mania and depression. Psychol Med 1999, 29:1307-1321.
3. Nygren T.E., Isen A.M., Taylor P.J., Dulin J. The influence of positive affect on the decision rule in risk situations: focus on outcome (and especially avoidance of loss) rather than probability. Organ Behav Hum Decis Process 1996, 66:59-72.
4. Sharot T., Guitart-Masip M., Korn C.W., Chowdhury R., Dolan R.J. How dopamine enhances an optimism bias in humans. Curr Biol 2012, 22:1477-1481.
5. Enkel T., Gholizadeh D., von Bohlen Und Halbach O., Sanchis-Segura C., Hurlemann R., Spanagel R., et al. Ambiguous-cue interpretation is biased under stress- and depression-like states in rats. Neuropsychopharmacology 2010, 35:1008-1015.
6. Harding E.J., Paul E.S., Mendl M. Animal behaviour: cognitive bias and affective state. Nature 2004, 427:312.
7. Papciak J., Popik P., Fuchs E., Rygula R. Chronic psychosocial stress makes rats more 'pessimistic' in the ambiguous-cue interpretation paradigm. Behav Brain Res 2013, 256:305-310.
8. Rygula R., Papciak J., Popik P. Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology 2013, 38:2188-2196.
9. Rygula R., Pluta H., Popik P. Laughing rats are optimistic. PLoS ONE 2012, 7:e51959.
10. Rygula R., Papciak J., Popik P. The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 2014, (in press).
11. Engstrom R.G., Kelly L.A., Gogerty J.H. The effects of 5-hydroxy-5(4'-chlorophenyl)-2,3-dihydro-5H-imidazo (2, 1-a) isoindole (mazindol, SaH 42-548) on the metabolism of brain norepinephrine. Archives internationales de pharmacodynamie et de therapie 1975, 214:308-321.
12. Gogerty J.H., Trafold J.H. Chemistry and pharmacology of mazindol. Triangle: Sandoz J Med Sci 1976, 15:25-36.
13. Heikkila R.E., Cabbat F.S., Mytilineou C. Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices. Eur J Pharmacol 1977, 45:329-333.
14. Nikiforuk A., Popik P. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Psychoneuroendocrinology 2011, 36:28-39.
15. Howell D.C. Statistical methods for psychology 1997, Wadsworth, Belmont, CA. 4th ed.
16. Howell L.L., Byrd L.D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 1991, 258:178-185.
17. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237:1219-1223.
18. Wise R.A. Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr 1984, 50:15-33.
19. Woolverton W.L., Kleven M.S. Multiple dopamine receptors and the behavioral effects of cocaine. NIDA Res Monogr 1988, 88:160-184.
20. Spealman R.D., Bergman J., Madras B.K., Melia K.F. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 1991, 258:945-953.
21. Brouard A., Pelaprat D., Boja J.W., Carroll F.I., Vial M., Kuhar M.J., et al. Potent cocaine analogs inhibit [3H]dopamine uptake in rat mesencephalic cells in primary cultures: pharmacological selectivity of embryonic cocaine sites. Brain Res Dev Brain Res 1993, 75:13-17.
22. Cline E.J., Scheffel U., Boja J.W., Carroll F.I., Katz J.L., Kuhar M.J. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. J Pharmacol Exp Ther 1992, 260:1174-1179.
23. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997, 386:827-830.
24. Scheel-Kruger J. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs. Eur J Pharmacol 1972, 18:63-73.
25. Woolverton W.L. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 1986, 24:531-535.
26. Barrett R.L., Appel J.B. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology (Berl) 1989, 99:13-16.
27. Callahan P.M., Appel J.B., Cunningham K.A. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology (Berl) 1991, 103:50-55.
28. Kleven M.S., Anthony E.W., Goldberg L.I., Woolverton W.L. Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390. Psychopharmacology (Berl) 1988, 95:427-429.
29. Bergman J., Kamien J.B., Spealman R.D. Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol 1990, 1:355-363.
30. Howell L.L., Byrd L.D. Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey. J Pharmacol Exp Ther 1992, 262:907-915.
31. Spealman R.D. Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers. Psychopharmacology (Berl) 1990, 101:142-145.
32. Rogerio R., Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacol Biochem Behav 1992, 43:631-633.
33. Yang X.M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol Biochem Behav 1992, 41:643-650.
34. Geracioti T.D., Post R.M. Onset of panic disorder associated with rare use of cocaine. Biol Psychiatry 1991, 29:403-406.
35. Blanchard D.C., Blanchard R.J. Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 1999, 23:981-991.
36. Costall B., Kelly M.E., Naylor R.J., Onaivi E.S. The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav 1989, 33:197-203.
37. Fontana D.J., Commissaris R.L. Effects of cocaine on conflict behavior in the rat. Life Sci 1989, 45:819-827.
38. Ettenberg A., Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berl) 1991, 103:455-461.
39. Geist T.D., Ettenberg A. Concurrent positive and negative goalbox events produce runway behaviors comparable to those of cocaine-reinforced rats. Pharmacol Biochem Behav 1997, 57:145-150.
40. Dawson G.R., Crawford S.P., Collinson N., Iversen S.D., Tricklebank M.D. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berl) 1995, 118:316-323.
41. Anderson M.H., Munafo M.R., Robinson E.S. Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task. Psychopharmacology (Berl) 2013, 226:601-613.
42. Chait L.D., Uhlenhuth E.H., Johanson C.E. Drug preference and mood in humans: mazindol and phenylpropanolamine. NIDA Res Monogr 1984, 49:327-328.
43. Chait L.D., Uhlenhuth E.H., Johanson C.E. The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans. Pharmacol Biochem Behav 1986, 24:1665-1672.
44. Defelice E.A., Chaykin L.B., Cohen A. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity. Curr Therap Res Clin Exp 1973, 15:358-366.
45. Wellman P.J. Systemic mazindol reduces food intake in rats via suppression of meal size and meal number. J Psychopharmacol 2008, 22:532-535.
46. Kluemper D., DeGroot L.M.L.T. State or trait: effects of state optimism on job-related outcomes. J Organ Behav 2009, 30:209-231.
47. Burman O.H., Parker R.M., Paul E.S., Mendl M.T. Anxiety-induced cognitive bias in non-human animals. Physiol Behav 2009, 98:345-350.